IoT Cybersecurity Must Be A Higher Priority In Fast-Moving Medtech Sector

While intenet-of-things security is becoming mainstream in health care,  the warnings of WannaCry two years ago and frequent malware issues for hospital IT systems show that implementation of cybersecurity best practice is still not yet at the forefront of many health technology companies’ thoughts. This is not their fault, says Oxford Information Labs’ Stacie Hoffmann, but it must soon become a priority in today’s fast-evolving health care ecosystem.

Health concept: pixelated Heart icon on digital background, empty copyspace for card, text, advertising

“Not enough thought goes into the security concerns surrounding the internet of things (IoT) when networked medical devices are being adopted in the health care environment.”

So says Oxford Information Labs’ Stacie Hoffmann, lead author of a new white paper issued today by the IoT Security Foundation (IoTSF) on good security regimes for health care providers

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Digital Technologies

More from Medtech Insight

Disparities — Including Financials Shortcomings — Remain In Women’s Health, Execs Say

 

FemTech leaders discussed some of the barriers that remain in unlocking the full potential of the women’s health market during SiS New York last week. They also offered solutions.

Mirvie Launches Predictive Blood Test For Preeclampsia

 
• By 

Mirvie launched Encompass, a blood test to help identify women over age 35 who are at moderate risk for preeclampsia, and will conduct additional studies to support reimbursements from payers.

Bringing Israeli Medical Device Candidates To The Right Partners In The US

 
• By 

Despite regional unrest, it is business as usual for medtech innovators and investors in Israel as evidenced by continued high-value M&A of locally developed technologies. Irit Yaniv, co-chair of the medtech session at the upcoming BioMed Israel 2025, explained the unique dynamics of Israeli medtech innovation.